Although CYR61 up-regulation was previously described in BE samples where dysplasia/EA is already present [39], our work is the first to describe that such up-regulation is in fact a very early event in Barrett’s tumorigenic process, being an indicator for a later establishment of dysplasia/EA, since it is detected in BE index biopsies. This evidence concerns the gene CCN1 and dysplasia.